Investors in the region are awaiting India's HSBC Composite flash purchasing managers' index reading for August expected ...

DS 6157: Daiichi Sankyo Company DS-6157 is a potential first-in-class GPR20 targeting ADC and the fifth DXd ADC in the oncology pipeline of Daiichi Sankyo to enter clinical development. ADCs are ...

A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...

Aurobindo Pharma shares fell 4.67 per cent to hit a high of Rs 1,039.30 on BSE, commanding a market capitalisation of just ...

Reports suggested it has emerged as the frontrunner to acquire Prague-based Zentiva for $5 to $5.5 billion. If completed, this would be the largest-ever acquisition by an Indian pharma company.

Opportunistically placed pop-up screening stations may help improve detection and awareness of cardiovascular risk factors ...

Olutasidenib could dramatically extend survival and reduce dependence on transfusions for certain patients with myelodysplastic syndrome, according to results of a phase 1/2 investigation.Individuals ...

The FGFR inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of conditions such as urothelial carcinoma, cholangiocarcinoma, and ...

On Wall Street, the Nasdaq .IXIC and S&P 500 .SPX fell overnight as investors sold tech stocks and moved into less highly ...